FDA: Johnson & Johnson's COVID-19 vaccine appears to meet requirements for emergency use

The FDA says Johnson and Johnson's COVID-19 vaccine meets all requirements for emergency use.

News 12 Staff

Feb 24, 2021, 11:12 PM

Updated 1,205 days ago

Share:

The FDA says Johnson and Johnson's COVID-19 vaccine meets all requirements for emergency use.
It says Johnson & Johnson's COVID-19 vaccine is 66% effective at preventing COVID illness. That's compared to 95% for Pfizer and Moderna.
Dr. Manisha Juthani, an infectious disease physician with Yale Medicine, says that data hasn't been broken down by age yet but the shot could be more effective in younger age groups.
The Johnson & Johnson vaccine is also easier to store and administer. State officials say the federal government is hoping for 20 million doses of the Johnson & Johnson vaccine by the end of next month.
The shot is expected to be approved for use after Friday's hearing.
Juthani says the efficacy numbers shouldn't scare people off.
Juthani urges those 65 and up who haven't been vaccinated yet to sign up now before the eligibility pool gets much wider on Monday.


More from News 12